Cite
HARVARD Citation
Piha-Paul, S. et al. (n.d.). 372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager. Journal for immunotherapy of cancer. p. A397. [Online].